Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ04
- Pharmacological subgroupJ04A
- Chemical subgroupJ04AB
- Chemical substanceJ04AB05Rifapentine
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 1 medicine
United States
FDA · 1 medicine
All medicines with Rifapentine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
3 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rifapentine Tablets | Canada | 150 MG | Tablet | Authorised | Macleods Pharmaceuticals Limited |
| Priftin | United States | 150MG | tablet | Marketed | Sanofi Aventis US |
| Rifapentina | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda |



